ArticlePharmaceuticals (Basel, Switzerland)2022

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors.

Sarah S Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.